
Join us on Saturday, March 20th, 2021, at 12:00 pm ET for a webinar featuring a discussion around the latest in emerging stem-cell therapies for retinal degenerative diseases, including therapies in, or moving toward, clinical trials.
Jump to Section
The Foundation’s best-in-class genetic testing program enables any eye care professional in the US to order no-cost genetic testing through the Foundation’s My Retina Tracker Program and genetic counseling for patients clinically diagnosed with an IRD.
The partnership includes genetic testing provided by Blueprint Genetics, which utilizes a state-of-the-art genetic testing panel for IRDs, and genetic counseling from InformedDNA, which are experts in helping patients understand what the test results mean for them and their families.
Also, patients can upload information about their condition to the My Retina Tracker Registry to get on the radar screen of researchers and therapy developers around the world, including those recruiting for clinical trials for emerging therapies.
Learn details about the Foundation’s My Retina Tracker Genetic Testing Program and Patient Registry.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
The Foundation Fighting Blindness meets all 20 Better Business Bureau Charity Standards.
Sign Up to Receive Updates and Communications from the Foundation!
Sign UpGet in Touch
Foundation Fighting Blindness
Phone: (800) 683-5555
Donations can be mailed directly to:
Foundation Fighting Blindness, P.O. Box 45740, Baltimore, MD 21297-5740
© 2021 Foundation Fighting Blindness, All Rights Reserved. The Foundation Fighting Blindness is a qualified 501(c)(3) non-profit organization and all donations are tax deductible. EIN 23-7135845.